4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH140152D                                                                                                             Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      4-Antibody AG (4-Antibody) is a biopharmaceutical company, based in Switzerland.
                                                                                                              4-Antibody AG, Pharmaceuticals & Healthcare, Key
      The company develops novel technology for the efficient discovery and development
                                                                                                              Facts
      of therapeutic antibodies for the treatment of serious medical conditions such as
      infectious diseases, oncology and autoimmunity/inflammation. 4-Antibody focuses                          Web Address                            www.4-antibody.com
      on development of fully human antibodies. The company develops its antibodies
                                                                                                               Revenue (US$ million)                                  NA
      with the help of its proprietary Hu-PAC technology that uses a unique protocol to
      produce fully human monoclonal antibodies for any antigen target. It is partnered                        Number of Employees                                    NA
      with Universities of Erlangen, Würzburg & Regensburg and Boehringer Ingelheim.                           GlobalData
      The company has its presence in the market of Germany.

      Financial Deals Landscape
        4-Antibody AG, Pharmaceuticals & Healthcare, Deals by Type,                       4-Antibody AG, Pharmaceuticals & Healthcare, Deals By
        2007 to YTD 2013                                                                  Year, 2007 to YTD 2013


                                                                                                                                                      2
                                                                                                          2




                                                                                           No. of Deals
                                                                                                                 1                         1                1          1
                                                                                                          1


                                                                                                                           0      0
                                                                                                          0
                                                                                                               2007       2008   2009     2010    2011     2012       YTD
                                                                                                                                                                      2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         4-Antibody AG, Pharmaceuticals & Healthcare, Deals By                            4-Antibody AG, Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         6     5
                                                                                                                      2
          No. of Deals




                                                                                           No. of Deals




                         5              4                                                                 2
                         4
                         3                                                                                                            1           1               1
                         2                                                                                1
                         1                       0         0         0
                         0
                             Europe   North     Asia-    Middle   South                                   0
                                      Americ   Pacific    East     and                                           Oncology Immunol              Infectiou   Pharmac
                                        a                 and     Central                                                   ogy                s Disease    euticals
                                                         Africa   Americ                                                                                      and
                                                                    a                                                                                      Healthcar
                                                                                                                                                               e


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




4-Antibody AG - Pharmaceuticals & Healthcare - Deals and                                                                                          Reference Code: GDPH140152D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       4-Antibody AG, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .......................................................................... 4
       4-Antibody AG, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ........................................................................... 5
       4-Antibody AG, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ...................................................................... 6
       4-Antibody AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ............................................................ 7
       4-Antibody AG, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013........................................................................ 8
       4-Antibody AG, Pharmaceuticals & Healthcare, Deal Details ............................................................................................................. 9
          Venture Financing........................................................................................................................................................................... 9
             4-Antibody Secures Additional $13.7 Million Through Series A Financing Round ...................................................................... 9
          Partnerships.................................................................................................................................................................................. 11
             4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research.............................. 11
             Evotec Enters Into Agreement With 4-Antibody For Antibody Detection ................................................................................... 13
             4-Antibody Enters Into Co-Development Agreement With Human Genome Sciences.............................................................. 14
             4-Antibody Enters Into Co-Development Agreement With Ludwig Institute............................................................................... 15
             4-Antibody Enters Into Long-Term Collaboration Agreement With Boehringer Ingelheim ......................................................... 16
       4-Antibody AG - Key Competitors .................................................................................................................................................... 17
       Key Employees ................................................................................................................................................................................ 18
       Locations And Subsidiaries .............................................................................................................................................................. 19
          Head Office ................................................................................................................................................................................... 19
       Appendix .......................................................................................................................................................................................... 20
          Methodology ................................................................................................................................................................................. 20
          About GlobalData ......................................................................................................................................................................... 20
          Contact Us .................................................................................................................................................................................... 20
          Disclaimer ..................................................................................................................................................................................... 20




4-Antibody AG - Pharm
				
DOCUMENT INFO
Description: 4-Antibody AG (4-Antibody) is a biopharmaceutical company, based in Switzerland. The company develops novel technology for the efficient discovery and development of therapeutic antibodies for the treatment of serious medical conditions such as infectious diseases, oncology and autoimmunity/inflammation. 4-Antibody focuses on development of fully human antibodies. The company develops its antibodies with the help of its proprietary Hu-PAC technology that uses a unique protocol to produce fully human monoclonal antibodies for any antigen target. It is partnered with Universities of Erlangen, Würzburg & Regensburg and Boehringer Ingelheim. The company has its presence in the market of Germany. 4-Antibody is headquartered in Basel, Switzerland.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.